Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Projected cash position below 1.5M CAD at June 30th .....

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Jun 01, 2022 10:20pm

253 Views

Post# 34725204

Projected cash position below 1.5M CAD at June 30th .....

SO ........

How and when do we bolster the cash position.

The naive and questionable bullboarders suggested the "muted cash burn" would continue on and allow adequate cash through 2022. I had suggested less cash was burned as a result of squelched trial activity as a result of CV19...

We burned 1.1 M in cash in Q1 and stood at 2.5M in cash at March 31/22 ..You do the math!

Serious replies only please

<< Previous

Bullboard Posts

Next >>

Canada-U.S. space collaboration to enhance orbital launch capabilities